Company news
Halberd Corp. news in 2021
Halberd Corp.'s news releases, calls and decks from 2021, newest first.
Halberd Corporation's Scientific Breakthrough: Conjugating Metallic Particles to SARS-CoV-2 and E. Coli Antigens
March 29, 2021
Halberd Corporation Completes Compilation of Medical Articles in Support of Nutraceuticals in Their VITA-SHIELD-MAX(TM) Immune Booster
March 22, 2021
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application Covering Extracorporeal Treatment of COVID-19 and Other Medical Maladies
March 17, 2021
Halberd Corporation Starts VITA-SHIELD-MAX(TM) Immunity Boosting Nutraceutical Production
March 15, 2021
Halberd Corporation Files VITA-SHIELD-MAX(TM) Trademark for Immunity Boosting Nutraceutical
March 10, 2021
Halberd Corporation's CEO Interviewed on "The Stock Day Podcast" - Focus on Halberd's New 20x Affinity Neutralizing SARS-COV-2 Antibody
March 8, 2021
Halberd's 2nd Proprietary Antibody Against SARS-COV-2 Spike Protein Demonstrates Neutralizing Affinity 20 Times Greater
March 1, 2021
Halberd Collaborates with GreenBioAZ, Inc. for the Development of its Patent Pending Radio Frequency Technology to Eliminate Disease Pathogens
February 15, 2021
Halberd Corporation's CEO Interviewed on The Stock Day Podcast and on MoneyTV
January 31, 2021
This Week on MoneyTV with Donald Baillargeon, 1/29
January 28, 2021
Halberd Corporation’s Research Breakthrough - Qualitative & Quantitative Measurement of Covid-19 Antigens and/or Antibodies
January 24, 2021
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)
January 13, 2021
Halberd Corporation’s Covid-19 Efforts Recognized in Wall Street PR News Article
January 11, 2021
Halberd Corporation 2020 Year End CEO Letter
January 3, 2021